---------参考文献---------
[1]Xue Yu, Yan Xing,et al. Effects of a Formula with scGOS/lcFOS (9:1) and Glycomacropeptide (GMP) Supplementation on the Gut
Microbiota of Very Preterm Infants [J]. Nutrients, 2022, 14(9): 1901.
[2]李在玲,张婷等.肠道微生态与婴幼儿免疫[J].临床儿科杂志,2020,38(11):801-807.
[3]Colin Hill, Francisco Guarner, et al. Expert consensus document: The International Scientific Association for
Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. GASTROENTEROLOGY & HEPATOLOGY 11,506–514 (2014).
[4]杨月欣,葛可欣等.中国营养科学全书(第2版)[M].北京:人民卫生出版社,2020:2228-2233.
[5]王贵强,王立祥等.活出健康:免疫力就是好医生[M].北京:人民卫生出版社,2020:308-309.
[6]刘波,刘通通等.益生元及其应用研究进展[J].食品与药品,2021,23(5):5-9.
[7]黄志华,郑跃杰等.实用儿童微生态学[M].北京:人民卫生出版社,2014:1998-2001.
[8]中国食品科学技术学会益生菌分会.后生元的研究现状及产业应用[J].中国食品学报,2022,22(8):417-421.
[9]Seppo Salminen, Bernd Stahl,et al. Infant Formula Supplemented with Biotics: Current Knowledge and Future Perspectives [J]. Nutrients, 2020, 12(7): 1952.
联系客服